Skip to main content

Court of Appeals Reinstates Birmingham Hip Implant Lawsuit

Court of Appeals Reinstates Birmingham Hip Implant Lawsuit

Court of Appeals Reinstates Birmingham Hip Implant Lawsuit

Introduction

The 9th Circuit U.S. Court of Appeals confirmed on restoring a Birmingham Hip Resurfacing lawsuit filed by a plaintiff against Smith & Nephew alleging the manufacturer of failing to warn about the system's health risk.

The lawsuit, filed by the plaintiff in April 2016, indicates the hip implants were defective and not compliant to the federal Food, Drug and Cosmetics Act and its regulations. The case was dismissed by the district court which was reinstated by a common three-judge appeals court panel. The Court of Appeals states that the plaintiff’s proposed amended complaint sufficiently alleges a failure-to-warn claim under Arizona law.

Several Birmingham Hip Replacement lawsuits are federally-filed against Smith & Nephew, 140 of which have been combined into a major federal litigation. Hip replacement lawsuits continue to be filed under a related hip litigation involving Stryker Hip Replacement lawsuits, centralized before U.S. District Judge Indira Talwani under MDL No. 2768 – in Re: Stryker LFIT V40 Femoral Head Products Liability Litigation.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!